Company — Leadership
The minds behindthe science.
Object Pharma is led by executives with deep experience in botulinum neurotoxin science, toxin production and pharmaceutical development.
Executive Leadership
Kenton Abel, PhD
CEO
Dan Radecki, MA, PhD
President
Aaron Chamberlain, PhD
CSO
Eric Chojnicki, PhD, MBA
Vice President of Product Development
Mike Goodnough, PhD
EVP, Toxin Production
Board of Directors
Dennis Fluet
Independent Board Member
Jesper Carvalho Anderson
Independent Board Member
Margaret Hines
Independent Board Member